You have 9 free searches left this month | for more free features.

Bone marrow transplantHigh risk hematologic malignancies

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hematologic Malignancies Trial in La Jolla (Cyclophosphamide 50 mg/kg IV Days 3 and 4 post transplant)

Suspended
  • Hematologic Malignancies
  • Cyclophosphamide 50 mg/kg IV Days 3 and 4 post transplant
  • La Jolla, California
    UCSD Medical Center
Jul 20, 2022

Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial (drug, radiation, procedure)

Not yet recruiting
  • Acute Leukemia
  • +4 more
  • (no location specified)
Oct 18, 2022

HIV, Hematologic Malignancies Trial run by the National Cancer Institute (NCI) (RIC, GVHD prophylaxis, allo HCT)

Not yet recruiting
  • HIV
  • Hematologic Malignancies
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 17, 2022

Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With

Active, not recruiting
  • Adult Acute Lymphoblastic Leukemia in Remission
  • +14 more
  • radiation therapy
  • +8 more
  • Columbus, Ohio
    Arthur G. James Cancer Hospital and Solove Research Institute at
Oct 7, 2022

Pathogenesis of Hematologic Malignancies

Enrolling by invitation
  • Acute Leukemia
  • +3 more
  • blood draw, bone marrow procedure, or tissue biopsy
  • Portland, Oregon
    OHSU Knight Cancer Institute
Sep 9, 2022

Acute Leukemia, MDS, T-lymphoblastic Lymphoma Trial (drug, radiation, procedure)

Not yet recruiting
  • Acute Leukemia
  • +6 more
  • (no location specified)
Dec 8, 2021

Hematologic Diseases, Hematologic Malignancy, Acute Lymphoblastic Leukemia Trial in Miami (device, procedure, drug)

Withdrawn
  • Hematologic Diseases
  • +5 more
  • CliniMACS
  • +7 more
  • Miami, Florida
    Miami Cancer Institute at Baptist Health, Inc.
Sep 26, 2022

Acute Leukemia of Ambiguous Lineage, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Seattle (procedure, drug,

Not yet recruiting
  • Acute Leukemia of Ambiguous Lineage
  • +8 more
  • Biospecimen Collection
  • +12 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 22, 2023

Tissue Specimens From Solid Tumors or Blood Disorders and Their

Recruiting
  • Neoplasms
  • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 21, 2023

    Myeloproliferative Disorders, Acute Myelogenous Leukemia, Chronic Myelogenous Leukemia Trial run by the NHLBI (T-cell replete

    Completed
    • Myeloproliferative Disorders
    • +4 more
    • T-cell replete PBPC allograft
    • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Oct 12, 2022

    Acute Leukemia, MDS, T-lymphoblastic Lymphoma Trial (drug, radiation, procedure)

    Not yet recruiting
    • Acute Lymphoblastic Leukemia
    • +6 more
    • Bone Marrow Hematopoeitic Cell Transplant (HCT)
    • +9 more
    • (no location specified)
    Sep 27, 2021

    Hematologic Malignancy, Myeloid Malignancy Trial in Memphis (Ruxolitinib, Mesna, Anti-thymocyte globulin (ATG))

    Recruiting
    • Hematologic Malignancy
    • Myeloid Malignancy
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Nov 7, 2022

    Hematological Malignancies - SANGUINE

    Recruiting
    • Hematologic Malignancy
    • Blood sampling for HemaChip screening/diagnostic testing
    • Bone marrow sampling
    • Olomouc, Czechia
    • +3 more
    Feb 9, 2023

    Leukemia, MDS Trial (drug, procedure, radiation)

    Active, not recruiting
    • Leukemia
    • Myelodysplastic Syndromes
    • (no location specified)
    Feb 17, 2022

    Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome Trial in United States (PRT1419)

    Recruiting
    • Acute Myeloid Leukemia
    • +3 more
    • Orange City, Florida
    • +7 more
    Oct 31, 2022

    Optimize Treatment Strategies for Older Hematologic Malignancies

    Recruiting
    • Leukemia, Acute
    • MDS
    • Bone Marrow or Peripheral Blood Graft (BMT)
    • +2 more
    • Philadelphia, Pennsylvania
      Abramson Cancer Center of the University of Pennsylvania
    Jan 7, 2022

    Previously Treated Myelodysplastic Syndrome, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid

    Recruiting
    • Previously Treated Myelodysplastic Syndrome
    • +3 more
    • Fludarabine Phosphate
    • +9 more
    • Chicago, Illinois
      University of Chicago Comprehensive Cancer Center
    Jan 7, 2022

    AML, ALL, MDS Trial in New York (Clofarabine, Fludarabine, Busulfan)

    Recruiting
    • AML
    • +8 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    May 13, 2022

    Acute Biphenotypic Leukemia, Acute Erythroid Leukemia in Remission, Acute Leukemia in Remission Trial in Seattle (drug,

    Terminated
    • Acute Biphenotypic Leukemia
    • +29 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jan 4, 2023

    Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute Trial in Worldwide (Decitabine, PDR001, MBG453)

    Active, not recruiting
    • Leukemia
    • +7 more
    • Boston, Massachusetts
    • +10 more
    Jan 19, 2023

    Hematological Malignancies Trial in Philadelphia (radiation, drug, genetic)

    Recruiting
    • Hematological Malignancies
    • Total Body Irradiation
    • +6 more
    • Philadelphia, Pennsylvania
      Thomas Jefferson University
    Feb 4, 2022

    Fludarabine Drug Exposure in Pediatric Bone Marrow

    Completed
    • Hematologic Malignancies
    • +7 more
    • San Francisco, California
      University of California, San Francisco
    Sep 27, 2021

    Clofarabine and Fludarabine Drug Exposure in Pediatric Bone

    Completed
    • Hematologic Malignancies
    • +7 more
    • San Francisco, California
      University of California, San Francisco
    Sep 27, 2021

    Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Mixed Phenotype Acute Leukemia Trial in United States (drug,

    Recruiting
    • Acute Lymphoblastic Leukemia
    • +7 more
    • Duarte, California
    • +26 more
    Aug 11, 2022